EGFR and glioblastoma: While the presence of EGFRvIII eccDNA may not be entirely implicated in the adaptive selection of EGFR-TKI-resistant tumor cells, EGFRvIII can be rapidly eliminated following TKI administration, thereby increasing resistance in glioblastoma cells [16,101].